Venus Concept Inc. (VERO)
NASDAQ: VERO · Real-Time Price · USD
2.140
-0.050 (-2.28%)
Oct 28, 2025, 4:00 PM EDT - Market closed
Venus Concept Employees
Venus Concept had 292 employees as of December 31, 2024. The number of employees decreased by 12 or -3.95% compared to the previous year.
Employees
292
Change (1Y)
-12
Growth (1Y)
-3.95%
Revenue / Employee
$205,846
Profits / Employee
-$141,558
Market Cap
3.98M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 292 | -12 | -3.95% |
| Dec 31, 2023 | 304 | -80 | -20.83% |
| Dec 31, 2022 | 384 | -23 | -5.65% |
| Dec 31, 2021 | 407 | 23 | 5.99% |
| Dec 31, 2020 | 384 | -141 | -26.86% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
VERO News
- 26 days ago - Venus Concept Announces $11.48 Million Debt-to-Equity Exchange Transaction - GlobeNewsWire
- 27 days ago - Venus Concept to Release Third Quarter of Fiscal Year 2025 Financial Results on November 13, 2025 - GlobeNewsWire
- 5 weeks ago - Cellulite Treatment Market Size to Reach USD 5.19 Billion by 2032, Driven by Rising Demand for Non-Invasive Aesthetic Solutions | S&S Insider - GlobeNewsWire
- 2 months ago - Venus Concept Inc. (VERO) Q2 2025 Earnings Call Transcript - Seeking Alpha
- 2 months ago - Venus Concept Announces Second Quarter 2025 Financial Results - GlobeNewsWire
- 3 months ago - Venus Concept to Release Second Quarter of Fiscal Year 2025 Financial Results on August 14, 2025 - GlobeNewsWire
- 4 months ago - Venus Concept Announces $6.5 Million Debt-to-Equity Exchange Transaction - GlobeNewsWire
- 5 months ago - Venus Concept Announces Closing of Up To $3.45 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules - GlobeNewsWire